BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38514754)

  • 21. mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro.
    Wang H; Edens NK
    J Lipid Res; 2007 May; 48(5):1099-107. PubMed ID: 17267946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion.
    Selige J; Hatzelmann A; Dunkern T
    J Cell Physiol; 2011 Aug; 226(8):1970-80. PubMed ID: 21520048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model.
    Mika D; Bobin P; Lindner M; Boet A; Hodzic A; Lefebvre F; Lechène P; Sadoune M; Samuel JL; Algalarrondo V; Rucker-Martin C; Lambert V; Fischmeister R; Vandecasteele G; Leroy J
    J Mol Cell Cardiol; 2019 Aug; 133():57-66. PubMed ID: 31158360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer: Phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target.
    Wright TA; Gemmell AO; Tejeda GS; Blair CM; Baillie GS
    Int J Biochem Cell Biol; 2023 Sep; 162():106453. PubMed ID: 37499270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
    Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
    Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
    Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
    Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
    Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
    Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
    Xu M; Yu X; Meng X; Huang S; Zhang Y; Zhang A; Jia Z
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F576-F588. PubMed ID: 31961716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics.
    Golkowski M; Shimizu-Albergine M; Suh HW; Beavo JA; Ong SE
    Cell Signal; 2016 Jul; 28(7):764-78. PubMed ID: 26643407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
    Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
    J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.
    Cheng H; Wu Z; He X; Liu Q; Jia H; Di Y; Ji Q
    Exp Ther Med; 2016 Oct; 12(4):2257-2264. PubMed ID: 27698721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors.
    Wang H; Peng MS; Chen Y; Geng J; Robinson H; Houslay MD; Cai J; Ke H
    Biochem J; 2007 Dec; 408(2):193-201. PubMed ID: 17727341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Martin AN
    Psychopharmacology (Berl); 2008 Mar; 197(1):115-26. PubMed ID: 18060387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
    Bartsch O; Bartlick B; Ivell R
    J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonists.
    Torphy TJ; Zhou HL; Foley JJ; Sarau HM; Manning CD; Barnette MS
    J Biol Chem; 1995 Oct; 270(40):23598-604. PubMed ID: 7559525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
    Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
    Front Oncol; 2022; 12():904969. PubMed ID: 35978822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal injection of phosphodiesterase 4B-specific siRNA attenuates neuropathic pain in rats with L5 spinal nerve ligation.
    Ji Q; Di Y; He X; Liu Q; Liu J; Li W; Zhang L
    Mol Med Rep; 2016 Feb; 13(2):1914-22. PubMed ID: 26706904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
    Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
    Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.